Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 16 results:
Συντάκτης [ Τίτλος![(Desc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-desc.png)
Φίλτρα: Συντάκτης is Cholongitas, Evangelos and Keyword is Adult [Clear All Filters]
Association between ratio of sodium to potassium in random urine samples and renal dysfunction and mortality in patients with decompensated cirrhosis..
Clin Gastroenterol Hepatol. 11(7), 862-7.
(2013). Comparison of creatinine and cystatin formulae with Chromium-ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis..
J Gastroenterol Hepatol. 32(1), 191-198.
(2017). Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis..
Clin J Am Soc Nephrol. 6(1), 84-92.
(2011). Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure..
Liver Transpl. 18(4), 405-12.
(2012). Critically ill patients with cirrhosis and low serum sodium..
J Clin Gastroenterol. 44(7), 523-4; author reply 524-5.
(2010).
(2011).
Impact of burnout syndrome on gastroesophageal reflux disease and irritable bowel syndrome in health care workers..
J Clin Psychiatry. 71(2), 209-10.
(2010). Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin..
Clin Transplant. 25(4), 614-24.
(2011).
(2014).
(2009).
RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit..
J Gastroenterol Hepatol. 24(10), 1639-47.
(2009).
(2014). Terlipressin therapy for renal failure in cirrhosis..
Eur J Gastroenterol Hepatol. 22(4), 481-6.
(2010). Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease..
J Hepatol. 51(5), 931-8.
(2009).
(2009).